SEC Warns of Charles Schwab Bond Fund Lawsuit Over Securities Violations

|

The U.S. Securities and Exchange Commission (SEC) has warned Charles Schwab Corp. that it could face a regulatory lawsuit over its handling of the Schwab YieldPlus Fund and Schwab Total Bond Market Fund, for which the company already faces pending securities fraud arbitration claims and an investor class action lawsuit for misleading investors.

Charles Schwab Corp. acknowledged last week that they received an SEC “Wells notice”, which indicates the regulators plan to recommend the company and the funds’ president be brought up on civil charges.

A number of arbitration claims over the funds and a Schwab YieldPlus class action lawsuit are already pending, after the funds lost much of their value when the sub-prime mortgage market crashed in late 2007, leaving investors with substantial losses. The investor claims allege that Schwab misled investors and failed to properly disclose the nature of the risks associated with certain securities held by the bond funds.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The Schwab YieldPlus funds are ultra-short bond funds that were heavily promoted as conservative investment alternatives to money market funds or cash. Despite being advertised to generate income with minimal changes in share price, the fund lost more than 30% of its value between June 2007 and June 2008 due to heavy investments in risky subprime mortgage securities, which some experts indicate violated the prospectus.

Although the SEC notice is not a formal charge of wrongdoing, nor is it a finding of guilt, the civil charges could increase the likely hood of a Schwab YieldPlus settlement for investors who are pursuing arbitration or class action claims, according to a report by Investment News. The company has already lost a number of arbitration cases through the Financial Industry Regulatory Authority (FINRA), resulting in losses of more than $20 million so far.

Charles Schwab Corp. indicates that they plan to respond to the SEC “Wells notice” over the Schwab YieldPlus Fund and Schwab Total Bond Market Fund to explain why they believe the civil lawsuit and enforcement charges are not appropriate.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.